Throughout the last three months, 7 analysts have evaluated Omega Healthcare Invts (NYSE:OHI), offering a diverse set of opinions from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 1 | 3 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 1 | 0 | 0 | 0 |
| 2M Ago | 1 | 0 | 1 | 0 | 0 |
| 3M Ago | 1 | 0 | 2 | 0 | 0 |
Analysts have set 12-month price targets for Omega Healthcare Invts, revealing an average target of $33.14, a high estimate of $36.00, and a low estimate of $30.00. Surpassing the previous average price target of $33.00, the current average has increased by 0.42%.
Breaking Down Analyst Ratings: A Detailed Examination
The analysis of recent analyst actions sheds light on the perception of Omega Healthcare Invts by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Nicholas Joseph | Citigroup | Raises | Buy | $35.00 | $32.00 |
| Connor Siversky | Wells Fargo | Raises | Overweight | $35.00 | $31.00 |
| Nate Crossett | Exane BNP Paribas | Announces | Neutral | $30.00 | - |
| Omotayo Okusanya | Deutsche Bank | Announces | Buy | $36.00 | - |
| Joshua Dennerlein | B of A Securities | Lowers | Neutral | $31.00 | $33.00 |
| Haendel St. Juste | Mizuho | Lowers | Buy | $34.00 | $35.00 |
| Michael Lewis | Truist Securities | Lowers | Hold | $31.00 | $34.00 |
Key Insights:
- Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Omega Healthcare Invts. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Omega Healthcare Invts compared to the broader market.
- Price Targets: Delving into movements, analysts provide estimates for the future value of Omega Healthcare Invts's stock. This analysis reveals shifts in analysts' expectations over time.
For valuable insights into Omega Healthcare Invts's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
Stay up to date on Omega Healthcare Invts analyst ratings.
Discovering Omega Healthcare Invts: A Closer Look
Omega Healthcare Investors Inc is a healthcare facility real estate investment trust that invests in the United States real estate markets. Omega's portfolio focuses on long-term healthcare facilities. Omega has one reportable segment consisting of investments in healthcare-related real estate properties located in the United States and the United Kingdom. Its core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (SNFs), assisted living facilities (ALFs), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities (specialty facilities) and medical office buildings (MOBs).
Understanding the Numbers: Omega Healthcare Invts's Finances
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Omega Healthcare Invts's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2023, the company achieved a revenue growth rate of approximately 65.22%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Real Estate sector.
Net Margin: Omega Healthcare Invts's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 22.98% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Omega Healthcare Invts's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 1.52%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Omega Healthcare Invts's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 0.59%, the company showcases efficient use of assets and strong financial health.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 1.42, caution is advised due to increased financial risk.
How Are Analyst Ratings Determined?
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
This article was generated by Benzinga's automated content engine and reviewed by an editor.